Member Info for chester18

What is very interesting is announcing that they are already way ahead of any other JV of this sort regarding speed and commitment.

They probably know that the tonnage has past their bare minimum, they don't know just how big Hav is going to be but the Telfer need is making the decision for them.

And as another interesting thought, we are still open to the north west and Scalywag is 6 kilometres north west of Hav. What if they more or less meet up....??

The geology would infer that they might and Newcrest will have far better intel about what actually is in the ground upto to the farthest step out.

Chester.

If they are still saying 'expanding mineralization' on February 12th it means all recent step outs must be finding reasonable grades. With SB sounding excited at each mention of Hav the new cores might have some further high grade interceptions.

Can only mean a much bigger resource than that used by Numis..... probably means that we can be confident that 10m ounces is already well passed.

Chester.

Figured that if this selling volume is a chunk of the warrants then money is flowing into GGP coffers. So bought another 250k knowing my little slice of cash might just pay for 20 mtrs of drilling at Scallywag...... hopefully the 29mtrs that's at 20grms / tonne....lol

Chester

Thanks Paddy

You were the only person I knew to ask but I take your point that you are not the front of all knowledge. May I just say, your work and information makes a massive difference because you help us novices understand what's happening at the drill site. So thanks once again for the help and direction.

Interesting times at Hav and tomorrow is no exception.

Chester.

Thanks Paddy

I've just given that a "good coat of looking at". So Primorous are intimating that there could be an as yet unknown Sub Region if the geology is consistent with that report on Telfer.
We know that Newcrest are a couple of months ahead of us on actual makeup of the ground but they are being extremely positive so the words used and the terminology in tomorrows report will act like lit up sign posts.

If they have a few more cores to report on that would also be great to hear.

Chester.

Hi Paddy

I asked you the question of the Prim comment about a Sub Region. What I was hoping you might be able to shed some light was where this sub region could be located.
They are obviously referring to something they have been told about but it doesn't fit with all the clues assembled by this board.

Am I right that anything below 1400mtrs is considered difficult to mine?

Chester.

Hi Paddygall

When Prem say that there could be another Sub-Region of the ore body, where are they saying that is?

From your work on Corebox we can see the drilling at depth, plus it's been stated that below 1,400 mtrs it's not really economic to mine, so where is this Sub-Region possibly located.

Hopefully you will see this message amongst the deluge...
Chester.

Sorry, they sold 16.4% of the 32m shares.

So approximately 5,220,000 shares at £1.533/share. Which is current market price.

Still a big discount from the original £5 that the fund paid.

Chester.

Hi SDG27

Yep my bad........

They sold 16.4% of the 32m so they actually received £1.533 / share which is the current price.

Thanks for pointing out my mistake.

Chester

Sold at a huge discount. The fund received approx £8m for the 31,833,770 shares which is 25p a share.

In July 2015 Woodford Group funds paid £5.00 a share (after consolidation Jan 2018).

https://www.thisismoney.co.uk/money/markets/article-7979387/MARKET-REPORT-Hargreaves-Lansdown-takes-blow-founder-flogs-550m-worth-shares.html

Chester.

Thanks for you post SDG27 appreciated.

That sale of (RENE) Ex- Woodford shares is at a huge discount. The fund received approx 25p a share but paid £5.00 a share in July 2015.

The fact that the Link management are holding on to all the Tissue Regenix shares speaks volumes.

Yet another factor to make me confident that this company will prove to be a winner.

Chester.

I think there is cross over from comments made that Newcrest are not allowed to buy GGP shares on the open market because of insider knowledge. They can offer to buy Hav or GGP totally at any time just can't see our BOD agreeing to anything until the Maiden Resource figure is officially rubber stamped.

Chester.

I don,t have L2 so can't check back to yesterday morning, but if it was a buy (which is likely) it shows that there are some out there that are still happy to accumulate at this very low price.

I will be so happy once we find out between MidCap and Placing.

Chester.

Hi Ruck

My comment is based on the USA Trial getting going by June / July that would give 5 months to the end December to hear some news.
I'm basing that on its an open label trial so important data could be shared early in the trial.
With it being a Combination Trial I may be wrong, I hope not.

May I also take is opportunity to wish your daughter-in-law my best wishes.
We need companies like Scancell, BionTech and such to give us the breakthroughs we need to achieve better outcomes against all forms of cancer.

All the best,
Chester.

Just seen an RNS on Reneuron (rene) a TR1 that the Link fund has reduced down to 0%

Chester.

Afternoon C7

I am very surprised that more people are not seeing the incredible upside potential of Scancells share price.
As we saw this last week positive news can land at any time and the SP does react very quickly.

I've determine that 7.00p to 8.00p is a great opportunity to gather some acorns before the real news starts to happen. With the current market cap a very lowly £32M and only 465 million shares in issue now is the time to build a decent holding.

I'm surprised that people are just ignoring the fact that on positive results Scancells platforms are worth huge amounts on money and we will be in the clinic with potentially three platforms inside 12 months.

Also, the first AvidiMab deal is possible inside 5 months, early data from the SC1B 1 Combi trial by year end and possible Biontech deal could be weeks away.

I'm with Martin Diggle, top up early.

Could not be more positive that 2020 is the year that Scancell prove to the market that 'binding' is where the future lies......

Chester.

Thanks Crumbs

I've been out all evening so I have only just seen your reply. Good to know that I'm still relatively sane and not making stuff up.
I was sure I'd read that the time limit was 12 months but could not find it.

So we are five months down the line and with the competition hot on their heels let's hope it speeds up the analysis process. A decision by June would be very welcome.

Chester.

When the first Avidimab agreement was RNS's in September last year I definitely remember a 12 month term being part of the assessment period. I've just gone back over the announcements at that time and the Proactive Investors interview with Cliff Holoway and I cannot find any reference to a time limit.

Question : Am I losing my marbles or is my memory correct that there was a 12 month period actually mentioned ?

Chester.

Hi WB,

A well reasoned and balanced post. I've been invested in TRX for 5/6 years and original bought when the share was around 22p so I've done my time so to speak. I see Tissue Regenix as a potential £300m to £500m Market Cap in 5 years +.

What they need right now is capital and if its a placing that raises enough funds to build the manufacturing base that can quadruple the turnover then I'm 100% behind it.

The reason the SP is down at 1.1p is in part these very facts. So the downside is already factored in.
If the placing comes and all the rabbits run off I will be very happy to buy more shares under 1p.
As long as they act decisively and put the finance issue to bed they can press on towards breakeven and profits.

Chester.

Due to all the recent developments and the the presentation by Cliff Holloway I've just sold some shares elsewhere to top up in Scancell 210k @ 7.19p so when it goes through just know it's a buy.

Chester